Bristol-Myers Squibb and Pfizer Present Large Real-World Observational Analysis of the Effectiveness and Safety of Direct Oral Anticoagulants Compared to Warfarin in Patients with Non-Valvular Atrial Fibrillation
Page (1) of 1 - 03/17/17||
(March 17, 2017)
Our Apologies, This article is no longer available, You may have followed an outdated link.
HTN - Health Technology Net
DMN Newswire Newsletter
Source:Copyright (c) Business Wire..
All Rights Reserved